PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

Slides:

Advertisements

Similar presentations

FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.

Advertisements

Martina Rastovac Mentor: A. Žmegač Horvat. Actor Patrick Swayze died after a 20-month battle with pancreatic cancer. He was 57.Patrick Swayze.

Pancreatic cancer By Linda Sircy.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.

What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

Breast Cancer By: Vincent Russo And Scott Jeffery.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

Ovarian Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”

Pit Pattern Classification in Colonoscopy A short introduction.

TRAB/2FTRAB/2O A Normal Breast Epithelium Supplemental Figure 1 iii iii iv TRAB/2FTRAB/2O GFs B M.W. None=0

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

Post-Resection CA 19-9 Predicts Overall Survival in Patients Treated with Adjuvant Chemoradiation; RTOG 9704 A. Berger, K. Winter, J. Hoffman, W. Regine,

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

中山大学肿瘤防治中心 SUN YAT-SEN UNIVERSITY CANCER CENTER Trends in the survival of patients with nasopharyngeal carcinoma in Sihui city, Guangdong province,

III. Cancer Defined as an Abnormal cell growth Defined as an Abnormal cell growth.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

8.1.4 Can it still be factored? Factoring Completely I can factor out a common factor.

Urinary Tract System Bladder Cancer.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Understanding Cancer and Related Topics

What is cancer? Mitosis- normal cell division Cancer- uncontrolled cell division (carcinoma) –Develops into a tumor Benign- does not spread –(Not Cancerous)

Differential Diagnoses September 25, You are a psychologist who has been referred 5 cases from the local school district. You have been asked to.

1 Sarcoma Ages >= ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at.

SEER Data Cancer Project Brett Langsjoen. SEER Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (NCI) Purpose: Collect.

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

*Be brief, yet thorough enough to allow recoding of the data fields from the text only! * Use accepted abbreviations from Abstractor’s Manual Appendix.

Radical vs Partial Nephrectomy for treatment of renal cell carcinoma at Prince Hussein Urology Centre Dr. Mohammad Alserhan Urology specialist Prince Hussein.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

DEPT OF RADIATION ONCOLOGY Prognostic Value of Post-Radiotherapy FDG PET in Head and Neck Cancer after Intensity Modulated Radiation Treatment Heming Lu.

ΟΡΓΑΝΩΣΗ ΚΑΙ ΔΙΟΙΚΗΣΗ ΕΠΙΧΕΙΡΗΣΕΩΝ 3 Ο ΜΑΘΗΜΑ. ΟΙ ΜΕΓΑΛΕΣ ΕΠΙΧΕΙΡΗΣΕΙΣ Η δημιουργία μεγάλων επιχειρήσεων είναι ένα από τα χαρακτηριστικά του 20 ου αιώνα.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

I.Северное Приладожье (Раахе- Ладога), гранитные купола и их обрамление.

NON-SMALL CELL LUNG CANCER

Breast Cancer Research in Pakistan

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Johns Hopkins Hospital Malignant and Benign Brain/CNS

A graph of the 15-year survival curves comparing localized melanoma (Stages I and II), regional metastases (Stage III), and distant metastases (Stage IV).

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Johns Hopkins Hospital Cancer Registry

Staging Cancer.

4 Relative survival Ontario Cancer Statistics 2016 Chapter 4: Relative survival.

Cancer Staging.

Stage Number observed at the start of each stage

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

4155 primary hepatocellular carcinoma with known diagnosis month/year

ОПЕРАТИВНА ПРОГРАМА “ИНОВАЦИИ И КОНКУРЕНТОСПОСОБНОСТ“ „Подобряване на производствения капацитет в МСП“

Hypothesis Testing: Two-Sample Inference

Solving Equations 3x+7 –7 13 –7 =.

Example Make x the subject of the formula

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Data Analytics course.

Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM

U A B II III I IV 94.

Mott Frank E. , MD, Sharma Neeraj , MD, Ashley Pandora CHEST

Presentation transcript:

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 357 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility and all/part of 1st course tx at JHH

ANALYTIC PANCREATIC CANCER AGE at DIAGNOSIS N = 357

ANALYTIC PANCREATIC CANCER by RACE N = 357

ANALYTIC PANCREATIC CANCER by AJCC STAGE, CLASS 1&2 N = 337 **N/A: Not eligible for AJCC staging; Insulinoma, malignant; Islet Cell Ca 20 females with Islet Cell Ca

ANALYTIC PANCREATIC CANCER CLASS 1&2 by TREATMENT AJCC STAGE I, N=36

ANALYTIC PANCREATIC CANCER CLASS 1&2 by TREATMENT AJCC STAGE II, N=128 *All Other treatment: Surg/Rad/Chem/Immun; Surg/Chem/Imm; Rad/Chem/Imm; Radiation only; Palliative

ANALYTIC PANCREATIC CANCER CLASS 1&2 by TREATMENT AJCC STAGE III, N=28

ANALYTIC PANCREATIC CANCER CLASS 1&2 by TREATMENT AJCC STAGE IV, N=98

ANALYTIC PANCREATIC CANCER OBSERVED SURVIVAL, CLASS 1 & 2 by STAGE

ANALYTIC PANCREATIC CANCER OBSERVED SURVIVAL, CLASS 1 & 2, ALL STAGES ©2010 National Cancer Data Base/Commission on Cancer